Autopsy report · NCT00134238
Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
Cause of deathNo reason given
Life of this trial
- Registered 1 year 9 months after it had already started.
- Ran for about 3 years 1 month before it stopped.
- 755 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Mixed Hyperlipidemia
- Interventions
- torcetrapib/atorvastatin; atorvastatin
- Participants
- 755
- Sites
- 51
- Countries
- Canada, Czechia, Finland, France, Netherlands, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.